Integrated Analysis of Multiple Microarray Studies to Identify Novel Gene Signatures in Non-alcoholic Fatty Liver Disease

por Jia, Xi, Zhai, Tianyu
Publicado 2019

Circulating Exosome Involves in the Pathogenesis of Autoimmune Thyroid Diseases Through Immunomodulatory Proteins

por Jia, Xi, Zhai, Tianyu, Zhang, Jin-an
Publicado 2021

Impact of Hypothyroidism on Echocardiographic Characteristics of Patients With Heart Valve Disease: A Single-Center Propensity Score-Based Study

por Zhai, Tianyu, Cai, Zhenqin, Zheng, Jiayu, Ling, Yan
Publicado 2020

TNRC6C Functions as a Tumor Suppressor and Is Frequently Downregulated in Papillary Thyroid Cancer

por Cai, Zhenqin, Zhai, Tianyu, Muhanhali, Dilidaer, Ling, Yan
Publicado 2021

Prevalence and Trends in Low Bone Density, Osteopenia and Osteoporosis in U.S. Adults With Non-Alcoholic Fatty Liver Disease, 2005–2014

por Zhai, Tianyu, Chen, Qi, Xu, Jing, Jia, Xi, Xia, Pu
Publicado 2022

Long Non-coding Antisense RNA TNRC6C-AS1 Is Activated in Papillary Thyroid Cancer and Promotes Cancer Progression by Suppressing TNRC6C Expression

por Muhanhali, Dilidaer, Zhai, Tianyu, Jiang, Jingjing, Ai, Zhilong, Zhu, Wei, Ling, Yan
Publicado 2018

Circ_0030998 promotes tumor proliferation and angiogenesis by sponging miR-567 to regulate VEGFA in colorectal cancer

por Jin, Longyang, Han, Chao, Zhai, Tianyu, Zhang, Xiaoyu, Chen, Chun, Lian, Lei
Publicado 2021

Effects of Platycodin D on apoptosis, migration, invasion and cell cycle arrest of gallbladder cancer cells

por Zhang, Xiaoyu, Zhai, Tianyu, Hei, Zhenyu, Zhou, Di, Jin, Longyang, Han, Chao, Wang, Jiandong
Publicado 2020

Metformin Reverses Hashimoto’s Thyroiditis by Regulating Key Immune Events

por Jia, Xi, Zhai, Tianyu, Qu, Chunjie, Ye, Jianjun, Zhao, Jing, Liu, Xuerong, Zhang, Jin-an, Qian, Qiaohui
Publicado 2021

Interfacial compatibility critically controls Ru/TiO(2) metal-support interaction modes in CO(2) hydrogenation

por Zhou, Jun, Gao, Zhe, Xiang, Guolei, Zhai, Tianyu, Liu, Zikai, Zhao, Weixin, Liang, Xin, Wang, Leyu
Publicado 2022

Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation

por Zhai, Tianyu, Zhang, Xiaoyu, Hei, Zhenyu, Jin, Longyang, Han, Chao, Ko, Audrey Tsznam, Yu, Xiaofeng, Wang, Jiandong
Publicado 2021

Corrigendum: Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation

por Zhai, Tianyu, Zhang, Xiaoyu, Hei, Zhenyu, Jin, Longyang, Han, Chao, Ko, Audrey Tsznam, Yu, Xiaofeng, Wang, Jiandong
Publicado 2021